Inflammatory breast cancer: what progress have we made?

@article{Dawood2011InflammatoryBC,
  title={Inflammatory breast cancer: what progress have we made?},
  author={Shaheenah Dawood and Massimo Cristofanilli},
  journal={Oncology},
  year={2011},
  volume={25 3},
  pages={264-70, 273}
}
Inflammatory breast cancer (IBC) is a rare and aggressive subtype of locally advanced breast cancer (LABC). Its diagnosis is primarily clinical; however, a pathological confirmation of invasive cancer is required. Historically, IBC was a uniformly fatal disease. A major advance in the last three decades has been the introduction of a multidisciplinary approach to the management of this aggressive disease, incorporating pre-operative chemotherapy, surgery, and radiation therapy; this approach… CONTINUE READING

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 28 extracted citations

DeepCancer: Detecting Cancer via Deep Generative Learning Through Gene Expressions

2017 IEEE 15th Intl Conf on Dependable, Autonomic and Secure Computing, 15th Intl Conf on Pervasive Intelligence and Computing, 3rd Intl Conf on Big Data Intelligence and Computing and Cyber Science and Technology Congress(DASC/PiCom/DataCom/CyberSciTech) • 2017
View 3 Excerpts

References

Publications referenced by this paper.
Showing 1-10 of 64 references

Increased angiogenesis and lymphangiogenesis in inflammatory versus noninflammatory breast cancer by real-time reverse transcriptase-PCR gene expression quantification.

Clinical cancer research : an official journal of the American Association for Cancer Research • 2004
View 16 Excerpts
Highly Influenced

AAJCC cancer staging manual, 6th ed

FL Breast. In Green, DL Page, ID Fleming, al et, editors
New York: Springer-Verlag: • 2002
View 9 Excerpts
Highly Influenced

International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment.

Annals of oncology : official journal of the European Society for Medical Oncology • 2011
View 1 Excerpt

Phase II study to evaluate the efficacy and safety of neoadjuvant lapatinib plus paclitaxel in patients with inflammatory breast cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology • 2010
View 2 Excerpts

Similar Papers

Loading similar papers…